Reduction in the Allelopathic Potential of Conocarpus erectus L. through Vermicomposting

The utilization of vermi-technology to reduce allelopathic effects is a cost-effective, efficient, and environmentally appropriate alternative to traditional chemical and mechanical methods. The current investigation was an effort to obtain vermicompost from C. erectus and its binary combination with soil and farmyard manure (FYM) using E. foetida. The pH, EC, organic carbon, macro and micro-nutrients, CO2 emission, the average growth rate of the worms, number of worms, number of cocoons, and weight gained by earthworms were analyzed by standard methods. The present study also investigated the effect of produced vermicompost on the growth and yield of mung beans (Vigna radiata L). The maximum reduction in soil pH was observed (6.47) in vermicompost of C. erectus leaves, among other treatments. The highest N (1.86%), P (0.15%), and K (0.41%) contents were found in the vermicompost of C. erectus leaves + FYM. Similarly, the maximum plant height (36.00 cm) was achieved in vermicompost of C. erectus leaves + FYM compared to other treatments. The highest SPAD value was observed (56.37) when the soil was treated with vermicompost (C. erectus leaves + FYM) @ 5 t ha?1, followed by the treatment where vermicompost (C. erectus leaves + soil) @ 8 t ha?1 was applied. The soil amendment of vermicompost (C. erectus leaves + FYM) @ 5 t ha?1 showed competitive results (in terms of the growth and yield parameters of mung beans) compared to other types of vermicompost and C. erectus biomass. This study has the potential to reduce the phytotoxicity of C. erectus biomass and transform it into a potent organic fertilizer through vermicomposting. © 2022 by the authors.7527/Punjab/NRPU/R&D/HEC/2017, Ph- II-MG-9)/PAKTURK/R&D/HEC/2018Taif University Researchers Supporting Project number (TURSP-2020/245), Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia. The authors are grateful to HEC for funding this research through the following HEC projects: “Vermicomposting: A resourceful organic fertilizer to improve agriculture production and soil health” (NRPU-HEC project no. 7527/Punjab/NRPU/R&D/HEC/2017) and “Vermicomposting: An Agricultural Waste Management Technology” (project vide letter no. (Ph- II-MG-9)/PAKTURK/R&D/HEC/2018, though Pak-Turk Researchers Mobility Grant Program Phase- 2)

EPIdemiology of Surgery-Associated Acute Kidney Injury (EPIS-AKI) : Study protocol for a multicentre, observational trial

More than 300 million surgical procedures are performed each year. Acute kidney injury (AKI) is a common complication after major surgery and is associated with adverse short-term and long-term outcomes. However, there is a large variation in the incidence of reported AKI rates. The establishment of an accurate epidemiology of surgery-associated AKI is important for healthcare policy, quality initiatives, clinical trials, as well as for improving guidelines. The objective of the Epidemiology of Surgery-associated Acute Kidney Injury (EPIS-AKI) trial is to prospectively evaluate the epidemiology of AKI after major surgery using the latest Kidney Disease: Improving Global Outcomes (KDIGO) consensus definition of AKI. EPIS-AKI is an international prospective, observational, multicentre cohort study including 10 000 patients undergoing major surgery who are subsequently admitted to the ICU or a similar high dependency unit. The primary endpoint is the incidence of AKI within 72 hours after surgery according to the KDIGO criteria. Secondary endpoints include use of renal replacement therapy (RRT), mortality during ICU and hospital stay, length of ICU and hospital stay and major adverse kidney events (combined endpoint consisting of persistent renal dysfunction, RRT and mortality) at day 90. Further, we will evaluate preoperative and intraoperative risk factors affecting the incidence of postoperative AKI. In an add-on analysis, we will assess urinary biomarkers for early detection of AKI. EPIS-AKI has been approved by the leading Ethics Committee of the Medical Council North Rhine-Westphalia, of the Westphalian Wilhelms-University Münster and the corresponding Ethics Committee at each participating site. Results will be disseminated widely and published in peer-reviewed journals, presented at conferences and used to design further AKI-related trials. Trial registration number NCT04165369

An integrative cross-omics analysis of DNA methylation sites of glucose and insulin homeostasis

Despite existing reports on differential DNA methylation in type 2 diabetes (T2D) and obesity, our understanding of its functional relevance remains limited. Here we show the effect of differential methylation in the early phases of T2D pathology by a blood-based epigenome-wide association study of 4808 non-diabetic Europeans in the discovery phase and 11,750 individuals in the replication. We identify CpGs in LETM1, RBM20, IRS2, MAN2A2 and the 1q25.3 region associated with fasting insulin, and in FCRL6, SLAMF1, APOBEC3H and the 15q26.1 region with fasting glucose. In silico cross-omics analyses highlight the role of differential methylation in the crosstalk between the adaptive immune system and glucose homeostasis. The differential methylation explains at least 16.9% of the association between obesity and insulin. Our study sheds light on the biological interactions between genetic variants driving differential methylation and gene expression in the early pathogenesis of T2D